4849 related articles for article (PubMed ID: 29272783)
21. Mortality impact, risks, and benefits of general population screening for ovarian cancer: the UKCTOCS randomised controlled trial.
Menon U; Gentry-Maharaj A; Burnell M; Ryan A; Kalsi JK; Singh N; Dawnay A; Fallowfield L; McGuire AJ; Campbell S; Skates SJ; Parmar M; Jacobs IJ
Health Technol Assess; 2023 May; ():1-81. PubMed ID: 37183782
[TBL] [Abstract][Full Text] [Related]
22. Overdiagnosis in breast imaging.
Evans A; Vinnicombe S
Breast; 2017 Feb; 31():270-273. PubMed ID: 28029492
[TBL] [Abstract][Full Text] [Related]
23. Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study.
Bernardi D; Macaskill P; Pellegrini M; Valentini M; Fantò C; Ostillio L; Tuttobene P; Luparia A; Houssami N
Lancet Oncol; 2016 Aug; 17(8):1105-1113. PubMed ID: 27345635
[TBL] [Abstract][Full Text] [Related]
24. Benefits and Harms of Breast Cancer Screening: A Systematic Review.
Myers ER; Moorman P; Gierisch JM; Havrilesky LJ; Grimm LJ; Ghate S; Davidson B; Mongtomery RC; Crowley MJ; McCrory DC; Kendrick A; Sanders GD
JAMA; 2015 Oct; 314(15):1615-34. PubMed ID: 26501537
[TBL] [Abstract][Full Text] [Related]
25. Patient preferences for breast cancer screening: a systematic review update to inform recommendations by the Canadian Task Force on Preventive Health Care.
Pillay J; Guitard S; Rahman S; Saba S; Rahman A; Bialy L; Gehring N; Tan M; Melton A; Hartling L
Syst Rev; 2024 May; 13(1):140. PubMed ID: 38807191
[TBL] [Abstract][Full Text] [Related]
26. Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement.
Siu AL;
Ann Intern Med; 2016 Feb; 164(4):279-96. PubMed ID: 26757170
[TBL] [Abstract][Full Text] [Related]
27. Breast Cancer Screening Trials: Endpoints and Overdiagnosis.
Jatoi I; Pinsky PF
J Natl Cancer Inst; 2021 Sep; 113(9):1131-1135. PubMed ID: 32898241
[TBL] [Abstract][Full Text] [Related]
28. Two-view digital breast tomosynthesis versus digital mammography in a population-based breast cancer screening programme (To-Be): a randomised, controlled trial.
Hofvind S; Holen ÅS; Aase HS; Houssami N; Sebuødegård S; Moger TA; Haldorsen IS; Akslen LA
Lancet Oncol; 2019 Jun; 20(6):795-805. PubMed ID: 31078459
[TBL] [Abstract][Full Text] [Related]
29. MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial.
Saadatmand S; Geuzinge HA; Rutgers EJT; Mann RM; de Roy van Zuidewijn DBW; Zonderland HM; Tollenaar RAEM; Lobbes MBI; Ausems MGEM; van 't Riet M; Hooning MJ; Mares-Engelberts I; Luiten EJT; Heijnsdijk EAM; Verhoef C; Karssemeijer N; Oosterwijk JC; Obdeijn IM; de Koning HJ; Tilanus-Linthorst MMA;
Lancet Oncol; 2019 Aug; 20(8):1136-1147. PubMed ID: 31221620
[TBL] [Abstract][Full Text] [Related]
30. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
31. Effect of three decades of screening mammography on breast-cancer incidence.
Bleyer A; Welch HG
N Engl J Med; 2012 Nov; 367(21):1998-2005. PubMed ID: 23171096
[TBL] [Abstract][Full Text] [Related]
32. Quality-of-life effects of screening mammography in Norway.
Zahl PH; Kalager M; Suhrke P; Nord E
Int J Cancer; 2020 Apr; 146(8):2104-2112. PubMed ID: 31254388
[TBL] [Abstract][Full Text] [Related]
33. Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with extended data.
Swedish Organised Service Screening Evaluation Group
Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):45-51. PubMed ID: 16434585
[TBL] [Abstract][Full Text] [Related]
34. Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies.
Mandelblatt JS; Stout NK; Schechter CB; van den Broek JJ; Miglioretti DL; Krapcho M; Trentham-Dietz A; Munoz D; Lee SJ; Berry DA; van Ravesteyn NT; Alagoz O; Kerlikowske K; Tosteson AN; Near AM; Hoeffken A; Chang Y; Heijnsdijk EA; Chisholm G; Huang X; Huang H; Ergun MA; Gangnon R; Sprague BL; Plevritis S; Feuer E; de Koning HJ; Cronin KA
Ann Intern Med; 2016 Feb; 164(4):215-25. PubMed ID: 26756606
[TBL] [Abstract][Full Text] [Related]
35. Screening for Breast Cancer: Evidence Report and Systematic Review for the US Preventive Services Task Force.
Henderson JT; Webber EM; Weyrich MS; Miller M; Melnikow J
JAMA; 2024 Jun; 331(22):1931-1946. PubMed ID: 38687490
[TBL] [Abstract][Full Text] [Related]
36. Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study.
Ciatto S; Houssami N; Bernardi D; Caumo F; Pellegrini M; Brunelli S; Tuttobene P; Bricolo P; Fantò C; Valentini M; Montemezzi S; Macaskill P
Lancet Oncol; 2013 Jun; 14(7):583-9. PubMed ID: 23623721
[TBL] [Abstract][Full Text] [Related]
37. Implementing recommendations for the early detection of breast and cervical cancer among low-income women.
Lawson HW; Henson R; Bobo JK; Kaeser MK
MMWR Recomm Rep; 2000 Mar; 49(RR-2):37-55. PubMed ID: 15580731
[TBL] [Abstract][Full Text] [Related]
38. Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study.
Zahl PH; Gøtzsche PC; Mæhlen J
Lancet Oncol; 2011 Nov; 12(12):1118-24. PubMed ID: 21996169
[TBL] [Abstract][Full Text] [Related]
39. Mammography screening reduces rates of advanced and fatal breast cancers: Results in 549,091 women.
Duffy SW; Tabár L; Yen AM; Dean PB; Smith RA; Jonsson H; Törnberg S; Chen SL; Chiu SY; Fann JC; Ku MM; Wu WY; Hsu CY; Chen YC; Svane G; Azavedo E; Grundström H; Sundén P; Leifland K; Frodis E; Ramos J; Epstein B; Åkerlund A; Sundbom A; Bordás P; Wallin H; Starck L; Björkgren A; Carlson S; Fredriksson I; Ahlgren J; Öhman D; Holmberg L; Chen TH
Cancer; 2020 Jul; 126(13):2971-2979. PubMed ID: 32390151
[TBL] [Abstract][Full Text] [Related]
40. Mammography screening. Benefits, harms, and informed choice.
Jørgensen KJ
Dan Med J; 2013 Apr; 60(4):B4614. PubMed ID: 23651722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
